-
Sulfaphenazole Derivatives Against TB with Lower CYP2C9
2026-08-24
The reference study optimized sulfaphenazole-derived sulfonamides to preserve antimycobacterial activity while reducing CYP2C9 inhibition, a potential source of drug–drug interactions. Compound 10d emerged as the leading example, combining a Mycobacterium tuberculosis MIC of 5.69 μg/mL with CYP2C9 inhibition weaker than 10 μM, providing a useful medicinal-chemistry framework for safer sulfonamide-based anti-TB discovery.
-
2,7-Dichlorodihydrofluorescein diacetate in PCOS
2026-08-24
A translational guide to using DCFH-DA as a context-aware intracellular ROS readout in granulosa-cell and PCOS research, connecting probe chemistry with THBS1/PI3K/AKT biology, assay controls, and the limits of mechanistic interpretation.
-
Oteseconazole: Translating CYP51 Selectivity Into Assays
2026-08-23
Oteseconazole (VT-1161) is more than a potent Candida-active azole: its fungal CYP51 selectivity creates a framework for better assay design and translational interpretation. This article connects mechanism, susceptibility testing, resistance biology, and the latest deuterated CYP51 inhibitor research.
-
PSPro Maps Spatial Proteomes at Cell-Type Resolution
2026-08-22
Mao et al. introduce PSPro, a proximity-labeling workflow that captures cell-type-specific proteomes directly from complex tissue slices while preserving spatial information. By combining optimized antibody-targeted labeling, affinity purification, and optional laser microdissection, the study profiles multiple cell types in pancreatic tumor and spleen tissue and resolves regional proteome heterogeneity.
-
RHO P347L Retinitis Pigmentosa: Endocytosis and Stress
2026-08-22
The 2026 study compares Class 1 RHO P347L and Class 2 RHO L125R mutations in humanized models to explain why P347L disease progresses more severely. Its evidence connects defective outer-segment trafficking, enhanced arrestin-associated endocytosis, lysosomal overload, and mitochondrial dysfunction, while indicating that neuroinflammation is a shared rather than severity-defining feature.
-
Epalrestat: Reframing Polyol Pathway Translation
2026-08-21
A translational framework for using Epalrestat to connect polyol pathway inhibition, oxidative stress research, diabetic neuropathy research, neuroprotection, and emerging questions in fructose-driven cancer metabolism.
-
5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
2026-08-20
This DMSO-soluble α2-adrenergic receptor agonist supports mechanistic studies of receptor signaling, immune rejection modulation, and post-surgical osteosarcoma recurrence models. The article translates reference findings into practical cell, hydrogel, and immune-assay workflows with troubleshooting guidance for solvent control, stability, and interpretation.
-
Itraconazole in Candida Biofilm Research
2026-08-20
Itraconazole is a triazole antifungal agent that can connect direct fungal growth assays with Candida biofilm, CYP3A4, and host-signaling studies. This workflow shows how to control solubility, separate antifungal activity from pathway effects, and translate PP2A–autophagy findings into more informative experiments.
-
Antipyrine B1886: CNS Workflow Benchmark
2026-08-19
Antipyrine, also called 1,5-dimethyl-2-phenylpyrazol-3-one, is a research-grade analgesic and antipyretic compound with reported high solubility and 99.98% purity. It can support pharmacokinetic studies and drug metabolism research, but its product specifications do not independently establish blood-brain barrier permeability.
-
Pravastatin Sodium: A Transporter-Aware Assay Strategy
2026-08-19
Pravastatin sodium is a powerful HMG-CoA reductase inhibitor, but its cellular effects depend on uptake, viability, and assay context. This guide combines cholesterol biology with hepatocyte transporter findings to improve experimental design and interpretation.
-
Firefly Luciferase mRNA: LNP Assay Guide
2026-08-18
Use Firefly Luciferase mRNA (ARCA, 5-moUTP) as a sensitive control for transfection, translation, cell viability workflows, and in vivo delivery studies. This guide connects practical reporter assay design with freeze-thaw LNP findings, helping researchers distinguish mRNA integrity problems from nanoparticle delivery failures.
-
Caspofungin: Reading Glucan-Targeting Assays
2026-08-18
Caspofungin is a lipopeptide antifungal drug whose value extends beyond potent glucan synthase inhibition. This article explains how to interpret susceptibility, persistence, resistance, and in vivo endpoints when evaluating Candida therapeutics.
-
Kir7.1 Glycosylation, GPCRs, and Channel Activity
2026-08-17
Carrington and colleagues showed that GPCRs regulate Kir7.1 through differential control of channel glycosylation rather than through the canonical GIRK mechanism. Their experiments connect reduced complex glycosylation with impaired Kir7.1 activity while preserving cell-surface abundance, providing a mechanistic framework for interpreting receptor–channel regulation and disease-associated Kir7.1 variants.
-
Affinity-Purified Goat Anti-Mouse IgG (H+L) Guide
2026-08-17
This practical guide shows how to use an HRP-conjugated goat anti-mouse reagent across Western blotting, ELISA, IHC, and ICC while controlling background and preserving signal. It also translates a bladder cancer mRNA–LNP study into concrete antibody-validation choices for measuring p21 restoration and tissue response.
-
Paroxetine Mesylate: A Translational Playbook
2026-08-16
A mechanism-first strategy for using Paroxetine Mesylate as both a serotonin transporter probe and a multi-target translational research tool across neuropharmacology, pharmacokinetics, and oncology.